Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG and SMM in Patients of Type II DM and BMI Between 27.5 - 32.5 kg / m²."

NCT04058730 is registered in ClinicalTrials.gov with Max Institute of Minimally Access, Metabolic & Bariatric Surgery as lead sponsor.

NCT NCT04058730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04058730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG and SMM in Patients of Type II DM and BMI Between 27.5 - 32.5 kg / m²."
Lead sponsor
Max Institute of Minimally Access, Metabolic & Bariatric Surgery
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2015
Completion date
December 31, 2021
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus